LifeVantage Corporation (LFVN)

Market Cap	141.25M
Revenue (ttm)	228.53M
Net Income (ttm)	9.81M
Shares Out	12.69M
EPS (ttm)	0.75
PE Ratio	14.84
Forward PE	10.97
Dividend	$0.18 (1.62%)
Ex-Dividend Date	Sep 8, 2025

Volume	334,584
Open	11.72
Previous Close	11.72
Day's Range	10.95 - 11.72
52-Week Range	9.00 - 27.38
Beta	0.42
Analysts	Strong Buy
Price Target	30.50 (+174.03%)
Earnings Date	Oct 28, 2025

About LFVN

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre- and pro-biotics and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fati...

• Industry: Packaged Foods
• Sector: Consumer Staples
• CEO: Steven Fife
• Employees: 238
• Stock Exchange: NASDAQ
• Ticker Symbol: LFVN
• Website: https://www.lifevantage.com

Financial Performance

In 2025, LifeVantage's revenue was $228.53 million, an increase of 14.17% compared to the previous year's $200.16 million. Earnings were $9.81 million, an increase of 233.84%.

Analyst Summary

According to 2 analysts, the average rating for LFVN stock is "Strong Buy." The 12-month stock price target is $30.5, which is an increase of 174.03% from the latest price.

Price Target

$30.5

(174.03% upside)

Analyst Consensus: Strong Buy